Boehringer Ingelheim Vetmedica, Inc.
Boehringer Ingelheim Vetmedica, Inc
2621 North Belt Highway
St. Joseph, MO
Boehringer Ingelheim Vetmedica, Inc., is a global leader in swine disease research and the development of innovative swine health products and swine diagnostic services to improve pork production. The swine division works with scientists, researchers, veterinarians, producers, processors and industry leaders to provide solutions to major swine diseases such as porcine reproductive and respiratory syndrome (PRRS), ileitis, Salmonella, erysipelas, Mycoplasma hyopneumoniae and other major swine diseases, as well as emerging diseases such as porcine circovirus associated diseases (PCVAD).
The swine division of Boehringer Ingelheim Vetmedica, Inc., traces its U.S. roots back to the early 1900s when hog cholera was the devastating disease of the period for hog producers.
Today with nearly 18 swine vaccines and other health products in its swine portfolio, state-of-the-art manufacturing and diagnostic facilities, and industry-leading research programs, Boehringer Ingelheim Vetmedica, Inc., is one of the premiere global swine health companies. More importantly, the swine division continues to seek effective solutions to costly swine health and production problems that challenge the swine industry.
- Ag markets moved generally higher Wednesday
- Infrastructure limits ag export growth, economist says
- Beetles, housefly larvae open new frontier in animal feed sector
- Oil pressured by Bernanke comments, crude stocks up
- Repainting “American Gothic:” Number of women farming triples
- Commentary: Severely ticked off
- Commentary: Ag must resist HSUS 'divide and conquer' strategy
- Outbreak of PEDV spreads to 13 U.S. states
- Smithfield Foods bid reflects China’s quality issues
- Finding the comedy in ag-gag
- National Pork Board elects new officers; Richter to lead
- Will Smith dethroned in latest Peterson Farm Bros. parody